Publicaciones científicas

Búsqueda avanzada

Inicio
> Grupos de Investigación
> Área de Cáncer
> Hepatología experimental y vectorización de fármacos (HEVEFARM)

Hepatología experimental y vectorización de fármacos (HEVEFARM)

ABCC2 is involved in the hepatocyte perinuclear barrier for small organic compounds.
Ruben Rosales Rodríguez; María Jesús Monte Río; Alba Mª García Blázquez; Óscar Briz Sánchez; Jose Juan García Marin
Biochemical Pharmacology ; 84, pp. 1651 - 1659
PubMed
MicroRNAs in biliary diseases
Munoz-Garrido P; García-Fernández de Barrena M; Hijona E; Carracedo M; Jose Juan García Marin; Bujanda L; Banales JM
World Journal Of Gastroenterology ; 18, pp. 6189 - 6196
PubMed
Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy
Martinez-Becerra P; Monte I; Marta Rodríguez Romero; Mª Ángeles Serrano García; Javier Vaquero Rodríguez; Rocío Rodríguez Macías; Del Rio A; Grañé-Boladeras N; Felipe Alfonso Jiménez Vicente; San-Martin FG; Pastor-Anglada M; Jose Juan García Marin
Pharmacological Research ; 66, pp. 419 - 427
PubMed
Cisplatin-Induced Chemoresistance in Colon Cancer Cells Involves FXR-Dependent and FXR-independent Up-Regulation of ABC Proteins
Elisa Herráez Aguilar; María Ester González Sánchez; Javier Vaquero Rodríguez; Marta Rodríguez Romero; Mª Ángeles Serrano García; Jose Juan García Marin; Óscar Briz Sánchez
Molecular Pharmaceutics ; 9, pp. 2565 - 2576
PubMed
No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
Martinez-Becerra P; Javier Vaquero Rodríguez; Marta Rodríguez Romero; Elisa Lozano Esteban; Anadon C; Rocío Rodríguez Macías; Mª Ángeles Serrano García; Grañé-Boladeras N; Luis Muñoz Bellvís; Alvarez L; Sangro B; Pastor-Anglada M; Jose Juan García Marin
Molecular Pharmaceutics ; 9, pp. 1693 - 1704
PubMed
Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
Jose Juan García Marin; Óscar Briz Sánchez; María Jesús Monte Río; A. G. Blazquez; R. I. R. Macias
Current Cancer Drug Targets ; 12, pp. 402 - 438
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer
Jose Juan García Marin; Fermin Sanchez de Medina; Beatriz Castano; Luis Bujanda; Marta Rodríguez Romero; Olga Martinez-Augustin; Rosario Del Moral-Avila; Óscar Briz Sánchez
Drug Metabolism Reviews ; 44, pp. 148 - 172
Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle
Molina-Jimenez F; Benedicto I; Dao Thi VL; Gondar V; Lavillette D; Jose Juan García Marin; Óscar Briz Sánchez; Moreno-Otero R; Aldabe R; Baumert TF; Cosset FL; Lopez-Cabrera M; Majano PL
Virology ; 425, pp. 31 - 39
PubMed
Characterization of the Role of ABCG2 as a Bile Acid Transporter in Liver and Placenta
Alba Mª García Blázquez; Óscar Briz Sánchez; Marta Rodríguez Romero; Ruben Rosales Rodríguez; María Jesús Monte Río; Javier Vaquero Rodríguez; Rocío Rodríguez Macías; Cassio D; Jose Juan García Marin
Molecular Pharmacology ; 81, pp. 273 - 283
PubMed
Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice
Fernández-Barrena MG; María Jesús Monte Río; Latasa MU; Uriarte I; Vicente E; Chang HC; Rodriguez-Ortigosa CM; Elferink RO; Berasain C; Jose Juan García Marin; Prieto J; Ávila MA
Journal Of Hepatology ; 56, pp. 367 - 373
PubMed

45 resultados

Páginas: 1 2 3 4 5 >

NoticiasNoticias
Zona del InvestigadorZona del Investigador